Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Products
  • Ramipril Capsules USP 10 mg
Where it was sold

Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.

Nationwide

Units affected
357,414 bottles
About this recall
Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India